Unapproved Stem Cell ‘Therapies’

Stuart SchlossmanAlternative therapies and devices for Multiple Sclerosis (MS), Multiple Sclerosis, Stem Cell Related


                                                                  

  


Click here to receive MS news via e-mail




Study identifies hot spots around the country

WebMD News from HealthDay
By Amy Norton
HealthDay Reporter
THURSDAY, June 30, 2016 (HealthDay News) — Hundreds of clinics across the United States are marketing unapproved stem celltreatments for conditions ranging from aging skin to spinal cord injuries, a new study finds.
In an online search, researchers found at least 570 clinics offering unapproved stem cell “therapies.” They tend to be concentrated in a handful of states — including Arizona, California, Colorado, Florida, New York and Texas — but are scattered across many other states, too.
Most often, the clinics market stem cell procedures for orthopedic conditions, such as arthritis and injured ligaments and tendons. This does have science behind it, but is still experimental, medical experts said.
In other cases with little or no supporting evidence, clinics hawked stem cell “facelifts” and therapies for serious conditions such as chroniclung diseaseParkinson’s disease and multiple sclerosis.
If these pricey stem cell treatments are unproven and unapproved by federal regulators, how can these clinics exist?
“I ask myself that question all the time,” said Leigh Turner, a bioethicist who worked on the study.
Turner, an associate professor at the University of Minnesota’s Center for Bioethics, said attention used to focus on “stem cell tourism” — where people travel to countries such as China, India and Mexico to get unproven treatments.
“I think there’s a misperception that everything here [in the U.S.] is regulated,” Turner said. “But these clinics are operating here, and on a relatively large scale.”
Stem cells are primitive cells with the potential to mature into various types of body tissue. Medical researchers have been studying the possibility of using stem cells to repair damaged tissue in a range of chronic ills — with limited success so far.
But the general public has heard about the “promise” of stem cells for years, and it can be easy to be taken in by clinics’ marketing tactics, Turner said.
Websites can, for instance, link to published medical studies that make their therapies seem legitimate, Turner said. “These businesses can be quite savvy,” he said. “I think it’s asking too much to just tell consumers to be wary. We need to be asking, why should these clinics be allowed to do this?”









MS Views and News
Providing educational information, resources and services for those affected by MS

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews